My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
HOUSTON – (Oct. 28, 2014) – A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial at The University…
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases JAMA Neurol. Published online October 20, 2014. doi:10.1001/jamaneurol.2014.2633 Importance Because vaccinations are common, even a small…
29 JUL 2012 DETROIT – Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms…
[youtube http://www.youtube.com/watch?v=qfHVX0fTTiI] Highlights: - Japanese mushroom extract active hexose correlated compound -Treating cervical cancer cells with AHCC led to the eradication of HPV, human papillomavirus, as well as a decrease…
These data suggest AHCC can eliminate HPV infections Japanese mushroom extract active hexose correlated compound (AHCC) may have role in prevention HPV-related cancers (March 23, 2014, Beaverton, OR) Treating…
- HPV-positive patients had a higher overall survival (OS) rate than HPV-negative patients (at two years post-treatment, 54.6 percent vs. 27.6 percent, respectively), according to research presented today at the…
Public release date: 7-Jun-2010 - At three years after treatment, 82 percent of patients with HPV-positive tumors were still alive - compared with 57 percent of patients with HPV-negative tumors…
Tuesday, July 09, 2013For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific evidence led…
Tuesday, July 09, 2013 For decades, women between the ages of 21 and 69 were advised to get annual screening exams for cervical cancer. In 2009, however, accumulating scientific…
Contact: Daniel Oppenheimer daniel.oppenheimer@utexas.edu 512-745-3353 University of Texas at Austin Designer bacteria may lead to better vaccines 61 new strains of genetically engineered bacteria may improve the efficacy of vaccines…
2008 study posted for filing Contact: Amy Molnar journalnews@bos.blackwellpublishing.net 201-748-8844 Wiley-Blackwell Article explores how mandate does not represent public health necessity Washington, D.C. – November 12, 2008 – The HPV…
2008 study posted for filing Contact: Kim Barnhardt kim.barnhardt@cma.ca 613-731-8610 x2224 Canadian Medical Association Journal Despite higher rates, HPV vaccine safe for use OTTAWA, ONTARIO, CANADA – The estimated rate…
Contact: Michele Baum BaumMD@upmc.edu 412-647-3555 University of Pittsburgh Schools of the Health Sciences Novel sequencing technique used at the University of Pittsburgh Cancer Institute reveals new cancer virus; reported in…
DETROIT – Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially…
Public release date: 13-Nov-2008 Washington, D.C. – November 12, 2008 – The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus,…
Public Release: 1-Sep-2008 OTTAWA, ONTARIO, CANADA – The estimated rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher – 5 to 20 fold – than…
Public release date: 10-Mar-2008 BIRMINGHAM, Ala. – A significant drop in abnormal Pap test results happened after girls and women were given a vaccine to prevent cervical cancer, according…
Public release date: 17-Jan-2008 PITTSBURGH, Jan. 17 – A new strategy to hunt for human viruses described in this week’s issue of the journal Science by the husband-and-wife team who…
You must be logged in to post a comment.